Building upon its sizeable presence in the oncology space in the Association of Southeast Asian Nations (ASEAN) region, Venus Remedies has received marketing approval from the Philippines, the second largest ASEAN market, for six key chemotherapy drugs.
The company has secured marketing authorisation for bortezomib cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines, thus making it a significant market for the company from the ASEAN region. With this, Venus Remedies has secured 525 marketing approvals for its oncology products across 76 Countries.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1530.00 |
Dr. Reddys Lab | 5802.00 |
Cipla | 1399.35 |
Zydus Lifesciences | 1051.90 |
Lupin | 1653.75 |
View more.. |